APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

被引:0
|
作者
Shimin Yang
Jingxiao Du
Wei Wang
Dongmei Zhou
Xiaowei Xi
机构
[1] Shanghai Jiao Tong University School of Medicine,Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Shanghai General Hospital
[2] Shanghai Jiao Tong University School of Medicine,Department of Ophthalmology, Shanghai General Hospital
来源
BMC Cancer | / 24卷
关键词
APOC1; Ovarian cancer; Immune response; M2 TAMs; Biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] APOE and APOC1 genetic polymorphisms in age-associated memory impairment
    Bartrés-Faz, D
    Clemente, IC
    Junqué, C
    Valveny, N
    López-Alomar, A
    Sánchez-Aldeguer, J
    López-Guillén, A
    Moral, P
    NEUROGENETICS, 2001, 3 (04) : 215 - 219
  • [32] Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
    Chao, Tai-Kuang
    Huang, Tien-Shuo
    Liao, Yu-Ping
    Huang, Rui-Lan
    Su, Po-Hsuan
    Shen, Hueng-Yuan
    Lai, Hung-Cheng
    Wang, Yu-Chi
    PLOS ONE, 2017, 12 (07):
  • [33] APOE and APOC1 genetic polymorphisms in age-associated memory impairment
    Bartrés-Faz D.
    Clemente L.C.
    Junqué C.
    Valveny N.
    López-Alomar A.
    Sánchez-Aldeguer J.
    López-Guillén A.
    Moral P.
    Neurogenetics, 2001, 3 (4) : 215 - 219
  • [34] APOC1 promotes the progression of osteosarcoma by binding to MTCH2
    Li, Renjie
    He, Huixian
    He, Xinxin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (04)
  • [35] A Population of M2 Macrophages Associated With Bone Formation
    Olmsted-Davis, Elizabeth
    Mejia, Julio
    Salisbury, Elizabeth
    Gugala, Zbigniew
    Davis, Alan R.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
    Zsófia Pénzváltó
    András Lánczky
    Julianna Lénárt
    Nóra Meggyesházi
    Tibor Krenács
    Norbert Szoboszlai
    Carsten Denkert
    Imre Pete
    Balázs Győrffy
    BMC Cancer, 14
  • [37] MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer
    Penzvalto, Zsofia
    Lanczky, Andras
    Lenart, Julianna
    Meggyeshazi, Nora
    Krenacs, Tibor
    Szoboszlai, Norbert
    Denkert, Carsten
    Pete, Imre
    Gyorffy, Balazs
    BMC CANCER, 2014, 14
  • [38] FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration
    Liu, Yuan-Jie
    Li, Jie-Pin
    Zhang, Ying
    Nie, Meng-Jun
    Zhang, Yong-Hua
    Liu, Shen-Lin
    Zou, Xi
    ONCOTARGETS AND THERAPY, 2021, 14 : 4099 - 4117
  • [39] Genotyping of four polymorphisms potentially associated with Alzheimer's disease:: A2M, APOC1, TNFα-850 and TNFα-308
    Christen, S.
    Tannenberg, R. K.
    Dodd, P. R.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 : 38 - 39
  • [40] Desmoglein-2 as a prognostic and biomarker in ovarian cancer
    Kim, Jiho
    Beidler, Peter
    Wang, Hongjie
    Li, Chang
    Quassab, Abdullah
    Coles, Cari
    Drescher, Charles
    Carter, Darrick
    Lieber, Andre
    CANCER BIOLOGY & THERAPY, 2020, 21 (12) : 1154 - 1162